Home
Cook Pharmica, LLC

Cook Pharmica, LLC Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domaincookpharmica.com

Year Founded2004

Employees501 - 1000

Annual Revenue$15M - $25M

Cook Pharmica, LLC

Cook Pharmica, LLC (including company regionals)

cookpharmica.com

See more website traffic and engagement information

Cook Pharmica, LLC Revenue up to June 2026 is 15M - 25M

revenue generated by Cook Pharmica, LLC top domains

Cook Pharmica, LLC top domains revenue over 3 years

Revenue for Cook Pharmica, LLC top domains

cookpharmica.com15M - 25M

See more with Sales Intelligence

Total visits to Cook Pharmica, LLC's top domains

Understand Cook Pharmica, LLC market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Cook Pharmica, LLC's top domains

Analyze Cook Pharmica, LLC engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Cook Pharmica, LLC's top domains

See how Cook Pharmica, LLC keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Cook Pharmica, LLC top competitors by domain

Top similar sites in June 2026, ranked by their affinity

catalent.comCompany NameCatalentEmployees> 10001HQUnited States, New Jersey, SomersetAnnual revenue> $1BTotal visits102.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Cook Pharmica, LLC

These are the website technologies, by industry, used by Cook Pharmica, LLC top domains

Advertising (8)

DoubleClick

Conversion & Analytics (4)

Google Analytics

Audio Video Media (2)

YouTube

Social (2)

Facebook Connect

More Technologies

2

See all

News & Signals from Cook Pharmica, LLC

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCatalent Pharma Solutions acquired Cookpharmica for $950M on Jan 1st '17.The focal point of the report was Catalent's acquisition of Cook Pharmica for $950 million, a privately-held biologics-focused contract development and manufacturing organization.